Key points are not available for this paper at this time.
S4. Targeting Polθ + PARP and Polθ + RAD52 induced dual synthetic lethality against HR -deficient MPN cells.
Share your take
Add a clinician perspective alongside expert commentary.
Sullivan-Reed et al. (2024) studied this question.